Business News • PR NewsWire • Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University

Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University

Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University

HANGZHOU, China, March 25, 2016 /PRNewswire/ -- The Cardiac Valve Research Institute ("the Institute") - a joint project between Venus Medtech (Hangzhou) Inc. ("Venus Medtech") and the Second Affiliated Hospital of Zhejiang University School of Medicine ("SAHZU") - has been officially...

View More : http://www.prnewswire.com/news-releases/venus-medtech-receives-investment-from-goldman-sachs-and-establishes-cardiac-val...

Releted News by prnewswire

Competitive Analysis of Defence Contractors

AARP Fraud Watch Network Campaign Targets 'IRS Imposter Scam'

Box Outside Solutions, the provider of solutions for simple problems, announces Piggyback, Earbuds Made for Sharing

Wood Pallet Market Development Trends and 2021 Forecasts

Screw Conveyors Market: 3.46% CAGR to 2020 Driven by APAC and Biomass Production